» Articles » PMID: 35746617

Memory CD8 T Cells Protect Against Cytomegalovirus Disease by Formation of Nodular Inflammatory Foci Preventing Intra-Tissue Virus Spread

Overview
Journal Viruses
Publisher MDPI
Specialty Microbiology
Date 2022 Jun 24
PMID 35746617
Authors
Affiliations
Soon will be listed here.
Abstract

Cytomegaloviruses (CMVs) are controlled by innate and adaptive immune responses in an immunocompetent host while causing multiple organ diseases in an immunocompromised host. A risk group of high clinical relevance comprises transiently immunocompromised recipients of hematopoietic cell transplantation (HCT) in the "window of risk" between eradicative therapy of hematopoietic malignancies and complete reconstitution of the immune system. Cellular immunotherapy by adoptive transfer of CMV-specific CD8 T cells is an option to prevent CMV disease by controlling a primary or reactivated infection. While experimental models have revealed a viral epitope-specific antiviral function of cognate CD8 T cells, the site at which control is exerted remained unidentified. The observation that remarkably few transferred cells protect all organs may indicate an early blockade of virus dissemination from a primary site of productive infection to various target organs. Alternatively, it could indicate clonal expansion of a few transferred CD8 T cells for preventing intra-tissue virus spread after successful initial organ colonization. Our data in the mouse model of murine CMV infection provide evidence in support of the second hypothesis. We show that transferred cells vigorously proliferate to prevent virus spread, and thus viral histopathology, by confining and eventually resolving tissue infection within nodular inflammatory foci.

Citing Articles

Cytomegalovirus inhibitors of programmed cell death restrict antigen cross-presentation in the priming of antiviral CD8 T cells.

Ebert S, Bohm V, Buttner J, Brune W, Brinkmann M, Holtappels R PLoS Pathog. 2024; 20(8):e1012173.

PMID: 39146364 PMC: 11349235. DOI: 10.1371/journal.ppat.1012173.


Refractory cytomegalovirus infections in Chinese patients receiving allogeneic hematopoietic cell transplantation: a review of the literature.

Yang D, Yao Y, Sun Y, Jiang E Front Immunol. 2024; 14:1287456.

PMID: 38187387 PMC: 10770847. DOI: 10.3389/fimmu.2023.1287456.


Direct antigen presentation is the canonical pathway of cytomegalovirus CD8 T-cell priming regulated by balanced immune evasion ensuring a strong antiviral response.

Buttner J, Becker S, Fink A, Brinkmann M, Holtappels R, Reddehase M Front Immunol. 2023; 14:1272166.

PMID: 38149242 PMC: 10749961. DOI: 10.3389/fimmu.2023.1272166.


Immunotherapy of cytomegalovirus infection by low-dose adoptive transfer of antiviral CD8 T cells relies on substantial post-transfer expansion of central memory cells but not effector-memory cells.

Holtappels R, Becker S, Hamdan S, Freitag K, Podlech J, Lemmermann N PLoS Pathog. 2023; 19(11):e1011643.

PMID: 37972198 PMC: 10688903. DOI: 10.1371/journal.ppat.1011643.


Immune-checkpoint expression in antigen-presenting cells (APCs) of cytomegaloviruses infection after transplantation: as a diagnostic biomarker.

Aghbash P, Rasizadeh R, Arefi V, Nahand J, Baghi H Arch Microbiol. 2023; 205(8):280.

PMID: 37430000 DOI: 10.1007/s00203-023-03623-8.

References
1.
Cicin-Sain L . Cytomegalovirus memory inflation and immune protection. Med Microbiol Immunol. 2019; 208(3-4):339-347. DOI: 10.1007/s00430-019-00607-8. View

2.
Mayo D, Armstrong J, Ho M . Reactivation of murine cytomegalovirus by cyclophosphamide. Nature. 1977; 267(5613):721-3. DOI: 10.1038/267721a0. View

3.
Einsele H, Roosnek E, Rufer N, Sinzger C, Riegler S, Loffler J . Infusion of cytomegalovirus (CMV)-specific T cells for the treatment of CMV infection not responding to antiviral chemotherapy. Blood. 2002; 99(11):3916-22. DOI: 10.1182/blood.v99.11.3916. View

4.
Reddehase M, Weiland F, Munch K, Jonjic S, Luske A, Koszinowski U . Interstitial murine cytomegalovirus pneumonia after irradiation: characterization of cells that limit viral replication during established infection of the lungs. J Virol. 1985; 55(2):264-73. PMC: 254929. DOI: 10.1128/JVI.55.2.264-273.1985. View

5.
Soderberg-Naucler C, Fish K, Nelson J . Reactivation of latent human cytomegalovirus by allogeneic stimulation of blood cells from healthy donors. Cell. 1997; 91(1):119-26. DOI: 10.1016/s0092-8674(01)80014-3. View